About
Services
Industries
Press & insights
resources
contact
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
On April 7, the Maine House voted 82–62 to advance Legislative Document (LD) 307, a bill sponsored by Rep. Melanie Sachs, D-Freeport, that would impose a moratorium on artificial intelligence (AI) data centers with loads of 20 MW or greater until Nov. 1, 2027. The bill would also create the Maine Data Center Coordination Council, tasked with evaluating how large-scale facilities could affect ratepayers, grid reliability, natural resources, and local communities—with a final report due to the legislature by February 2027. There are currently no large-scale AI data centers operating in Maine, but high-profile projects have recently been announced in Sanford and Jay.
Maine’s move is one of the most concrete legislative responses yet to a wave of anxiety sweeping across communities throughout the country. But according to Tracey Hyatt Bosman, managing director, and Tim Comerford, senior vice president at Biggins Lacy Shapiro & Co. (BLS & Co.), much of that anxiety is fueled by misunderstanding—and the industry has more work to do in telling its own story.
Tracey Hyatt Bosman develops and executes incentives and location selection strategies for BLS & Co.'s corporate and institutional clients. She is a certified economic developer with twenty years of professional experience across a wide range of sectors, including data centers, manufacturing, headquarters, back office and contact center operations, and logistics.
Tim Comerford leads a specially-designed interdisciplinary practice focused on assisting companies, developers, municipalities, and real estate advisors with issues that pertain to energy procurement, renewable installation, infrastructure assessments, and utility relocation, with a special focus on mission-critical facilities.
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
